Paradigm Biocapital Advisors LP → Tyra Biosciences, Inc. TYRA

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 8.83

9,414,018 shares short · -4.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $22.98M

Point72 Asset Mgmt

Other 13D/G Filings on Tyra Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-21	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-09-17	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	14,130,492	view →
2024-10-15	SC	Boxer Capital, LLC	—	—	view →

Other Filings by Paradigm Biocapital Advisors LP

Filed	Form	Issuer	Stake	Shares
2026-10-01	SCHEDULE 13G	Spyre Therapeutics, Inc.	—	—	view →
2026-06-26	SCHEDULE 13G	Viridian Therapeutics, Inc. VRDN	—	—	view →
2026-06-24	SCHEDULE 13G	MBX Biosciences, Inc. MBX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →